Hong Leong Asia Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Net income: S$87.4m (up 35% from FY 2023).
Profit margin: 2.1% (up from 1.6% in FY 2023). The increase in margin was driven by higher revenue.
EPS: S$0.12 (up from S$0.087 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) exceeded analyst estimates by 4.8%.
Looking ahead, revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Machinery industry in Singapore.
Performance of the Singaporean Machinery industry.
The company's shares are down 5.6% from a week ago.
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Hong Leong Asia's balance sheet.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Calculating The Intrinsic Value Of Gesundheitswelt Chiemgau AG (MUN:JTH)
Key Insights Using the Dividend Discount Model, Gesundheitswelt Chiemgau fair value estimate is €15.59 With €12.50 share price, Gesundheitswelt Chiemgau appears to be trading close to its estimated fair value Gesundheitswelt Chiemgau's peers seem to be trading at a higher discount to fair value based onthe industry average of 57% How far off is Gesundheitswelt Chiemgau AG (MUN:JTH) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to their present value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. It may sound complicated, but actually it is quite simple! We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Crunching The Numbers As Gesundheitswelt Chiemgau operates in the healthcare sector, we need to calculate the intrinsic value slightly differently. In this approach dividends per share (DPS) are used, as free cash flow is difficult to estimate and often not reported by analysts. This often underestimates the value of a stock, but it can still be good as a comparison to competitors. We use the Gordon Growth Model, which assumes dividend will grow into perpetuity at a rate that can be sustained. For a number of reasons a very conservative growth rate is used that cannot exceed that of a company's Gross Domestic Product (GDP). In this case we used the 5-year average of the 10-year government bond yield (1.3%). The expected dividend per share is then discounted to today's value at a cost of equity of 4.7%. Compared to the current share price of €12.5, the company appears about fair value at a 20% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate) = €0.5 / (4.7% – 1.3%) = €15.6 Important Assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Gesundheitswelt Chiemgau as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 4.7%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for Gesundheitswelt Chiemgau SWOT Analysis for Gesundheitswelt Chiemgau Strength Debt is well covered by earnings. Weakness Earnings declined over the past year. Dividend is low compared to the top 25% of dividend payers in the Healthcare market. Opportunity Current share price is below our estimate of fair value. Lack of analyst coverage makes it difficult to determine JTH's earnings prospects. Threat Debt is not well covered by operating cash flow. Looking Ahead: Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Gesundheitswelt Chiemgau, we've put together three pertinent items you should assess: Risks: Take risks, for example - Gesundheitswelt Chiemgau has 4 warning signs (and 1 which can't be ignored) we think you should know about. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! Other Top Analyst Picks: Interested to see what the analysts are thinking? Take a look at our interactive list of analysts' top stock picks to find out what they feel might have an attractive future outlook! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the MUN every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
ALSO Holding First Half 2025 Earnings: EPS: €3.38 (vs €3.40 in 1H 2024)
ALSO Holding (VTX:ALSN) First Half 2025 Results Key Financial Results Revenue: €5.93b (up 39% from 1H 2024). Net income: €43.0m (up 3.1% from 1H 2024). Profit margin: 0.7% (down from 1.0% in 1H 2024). The decrease in margin was driven by higher expenses. EPS: €3.38. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period ALSO Holding Earnings Insights Looking ahead, revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 9.2% growth forecast for the Electronic industry in Switzerland. Performance of the Swiss Electronic industry. The company's share price is broadly unchanged from a week ago. Risk Analysis Before you take the next step you should know about the 2 warning signs for ALSO Holding (1 is concerning!) that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
5 hours ago
- Yahoo
SAP Second Quarter 2025 Earnings: EPS Beats Expectations
SAP (ETR:SAP) Second Quarter 2025 Results Key Financial Results Revenue: €9.03b (up 8.9% from 2Q 2024). Net income: €1.70b (up 91% from 2Q 2024). Profit margin: 19% (up from 11% in 2Q 2024). EPS: €1.46 (up from €0.73 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period SAP EPS Beats Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 5.6%. Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Germany. Performance of the German Software industry. The company's shares are down 7.4% from a week ago. Balance Sheet Analysis Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of SAP's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
